Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Dermatology
»
Psoriasis
11. June 2026
Search
medline.ch
Psoriasis
Advanced search
Dermatology
Acne
Alopecia
Dermatitis
Infectious Skin Diseases
Photosensitivity Disorder
Psoriasis
Skin Neoplasms
Skin Ulcer
Urticaria
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 1403
Articles 1 - 20 / 28046
Targeting cutaneous inflammation: A review on advanced topical delivery systems and precision medicine in psoriasis.
Int J Pharm
Bobde M, Purohit A, Nema P, Sahu A, Kashaw V, Soni V, Kashaw SK.
PMID: 42264053 [PubMed - as supplied by publisher]
The skin microbiome as a key regulator of psoriasis: From dysbiotic drivers to host-directed therapeutics.
Microbiol Res
Xie T, Hao Y, Qin L.
PMID: 42263474 [PubMed - as supplied by publisher]
Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.
Dermatol Ther (Heidelb)
Ibba L, Di Giulio S, Malagoli P, Balato A, Bardazzi F, Travaglini M, Girolomoni G, Maurelli M, Burlando M, Caccavale S, Carrera CG, Carugno A, Dapavo P, Di Brizzi EV, Dini V, Gaiani FM, Guarneri C, Lasagni C, Loconsole F, Marzano AV, Megna M, Michelucci A, Potestio L, Ribero S, Sacchelli L, Zerbinati N, Mastorino L, Costanzo A, Narcisi A, Valenti M.
PMID: 42262460 [PubMed - as supplied by publisher]
New Tuberculosis Infection and Reactivation of Tuberculosis in Patients with Psoriasis or Psoriatic Arthritis Receiving IL-23 Inhibitors: A Systematic Literature Review.
Dermatol Ther (Heidelb)
Wang G, Youn SW, Chang CL, Saeki H.
PMID: 42262459 [PubMed - as supplied by publisher]
TOGETHER-PsA and the Case for Precision Phenotyping in Psoriatic Arthritis Commentary on: "Ixekizumab with Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults with Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial".
Arthritis Rheumatol
Caso F, Costa L, Scarpa R, Maione F, Giacomelli R, Ruscitti P.
PMID: 42261899 [PubMed - as supplied by publisher]
Role of the S1P/S1PR axis in inflammation and structural damage in psoriatic arthritis: a cross-sectional study with clinical, biochemical and imaging correlation.
RMD Open
Ruiz-Montesinos D, Mendoza-Mendoza D, Bocio Núñez J, Dominguez-Quesada C, Serrano-Guijo ML, Vázquez-Gámez MÁ, Rico MÁ, Colmenero MÁ, Perez-Venegas JJ, Montoya-García MJ, Giner M.
PMID: 42259576 [PubMed - in process]
Pilot Study of Gallic Acid Cream as a Potential Treatment for Plaque Psoriasis.
J Med Food
Greenway RR, Coulter AA, Zhang D, Greenway FL.
PMID: 42257840 [PubMed - as supplied by publisher]
Efficacy and safety of risankizumab in moderate to severe psoriasis: an updated systematic review and meta-analysis.
Ann Med Surg (Lond)
Shuja H, Farhan K, Wamiq U, Khan MS, Tariq MB, Shakir S, Uzair M, Salomon I.
PMID: 42254161 [PubMed]
Pregnancy Outcomes in Biologic-Exposed Psoriasis Patients: A Large Cohort Study of Real-World Safety.
J Am Acad Dermatol
Bar D, Pavlotsky F, Barzilai A, Yinon Y, Baum M.
PMID: 42250726 [PubMed - as supplied by publisher]
Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.
Ann Rheum Dis
Annfeldt TK, Händel MN, Haugegaard T, Henriksen M, Coates LC, Ogdie A, Tillett W, Goel N, Gladman DD, Orbai AM, de Wit M, Strand V, Mease PJ, FitzGerald O, Helliwell PS, Tugwell P, Leung YY, Christensen R.
PMID: 42248769 [PubMed - as supplied by publisher]
Beyond Psoriasis Area and Severity Index and Body Surface Area: An Italian Delphi Consensus on the Definition of Moderate Psoriasis.
Dermatol Ther (Heidelb)
Gargiulo L, Costanzo A, Malagoli P, Burlando M, Marzano AV, Dapavo P, Girolomoni G, Pappagallo G, Loconsole F, Carugno A, Piaserico S, Megna M, Campanati A, Conti A, Balato A, Trovato E, Dini V, Carrera CG, Bardazzi F, Guarneri C, Orsini D, Bernardini N, Venturini M, Ribero S, Narcisi A.
PMID: 42247111 [PubMed - as supplied by publisher]
Economic Impact of Timely Systemic Treatment of Psoriatic Disease in Comorbidity Risk Reduction: Literature Review and (Early) Economic Assessment.
Dermatol Ther (Heidelb)
Norton N, Nemeth Z, Nanda S, Dhirta A, Geale K, Vaz R.
PMID: 42247109 [PubMed - as supplied by publisher]
Real-world effectiveness and safety of apremilast in psoriatic arthritis: results from the multicenter Italian MAPSI II study.
Clin Rheumatol
Schenone C, Serban T, Tramontano G, Pendolino M, Foti R, Foti R, Bergamini A, Faggioli P, Iannone F, De Andres I, Favero M, Pirone C, Delle Sedie A, Camellino D, Bianchi G.
PMID: 42247059 [PubMed - as supplied by publisher]
Safety and efficacy of intralesional triamcinolone in the treatment of nail psoriasis: A systematic review and meta-analysis.
Dermatol Online J
Madani A, Barakeh M, Alshehri N, Altamimi I, Alobaid SA.
PMID: 42246338 [PubMed - in process]
Real-World Effectiveness and Safety of Deucravacitinib for Adult Patients with Plaque Psoriasis: A 16-Week Multicenter Retrospective Study of Monotherapy and Combination Therapy.
J Cutan Med Surg
Sood S, Bagit A, Maliyar K, Rankin BD, Abduelmula A, Rimke A, Georgakopoulos JR, Leung F, Devani AR, Mufti A, Prajapati VH, Vender R, Yeung J.
PMID: 42246277 [PubMed - as supplied by publisher]
Cost-Effectiveness Analysis of Bimekizumab against Interleukin-23 Inhibitors in Patients with Plaque Psoriasis in Japan.
Dermatol Ther (Heidelb)
Igarashi A, Shiraishi K, Saito S, Kudo T, Iizuka Y, Yamamura E, Hase M.
PMID: 42240734 [PubMed - as supplied by publisher]
Effects of Tirzepatide on Metabolic Parameters in Patients with Psoriasis and Obesity: 24-Week Real-World Study.
Dermatol Ther (Heidelb)
Gisondi P, Girolomoni G.
PMID: 42240733 [PubMed - as supplied by publisher]
Implementation of Risk-Stratified Tuberculosis Screening in Psoriasis Patients Receiving Biologic Therapy: A Retrospective Study from an Academic Medical Center.
J Am Acad Dermatol
Zhu A, Gao R, Romano PB, Gupta I, Bharol K, Flynn E, Tariq A, Makhoul K, Svoboda RM, Levin NA.
PMID: 42235599 [PubMed - as supplied by publisher]
Inflammaging and Senescence-Associated Secretory Phenotype (SASP) in Psoriasis - A Narrative Review of Potential Mechanisms and Anti-Inflammaging Strategies.
Psoriasis (Auckl)
Filipek K, Nowowiejska-Purpurowicz J, Flisiak I.
PMID: 42232205 [PubMed]
Curcumin alleviates depression-aggravated psoriasis by targeting MMP9-regulated apoptotic pathways.
iScience
Lu J, Zhou C, Ma Y, Zhang N, Diao Z, Chen D, Tian X, Yin Z.
PMID: 42231964 [PubMed]
Articles 1 - 20 / 28046
Page 1 of 1403
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy